Normal, thioglycollate-stimulated and BCG-activated mouse peritoneal macrophages were cultivated in vitro with the conditioned medium of mouse L-929 cells. The thioglycollateand BCG-macrophages rapidly proliferated, whereas normal macrophages grew more slowly. A clear morphological difference between the three types of macrophages in the culture was observed.Glucocorticoids inhibited the growth of the macrophages at pharmacological concentrations. Other steroids, progesterone, diethylstilbesterol and testosterone in that order, had a far lower growth-inhibiting effect. Macrophages cultured with 10-6 M dexamethasone had a reduced antimicrobial effect on Candida parapsilosis compared with that of the untreated cells. Choleragen had the same effect on the macrophages as glucocorticoids. The toxin inhibited growth at a concentration as low as 10 pg/ml and cells treated with 1 ng of choleragen per ml had decreased antifungal activity. Similarly, Escherichia coli lipopolysaccharide at 10 ng/ml inhibited the growth of thioglycollate-macrophages.However, macrophages incubated with the lipopolysaccharide had enhanced anticandida activity. Thus, the immunosuppressors glucocorticoid and choleragen inhibited both the increase in the number of macrophages and the microbicidal activity of the phagocytes. Lipopolysaccharide, an immunostimulant, stimulated macrophage activity, but was toxic for cell growth.The mononuclear phagocytes in blood (monocytes) and tissues (macrophages) play a variety of important roles in host defense responses. One mechanism for controlling the responses due to mononuclear phagocytic (MP) cells is activation of MP cells in the host, for example, by infection with certain bacteria (13). Activated MP cells enhance a variety of cellular functions including killing of intracellular pathogens (12, 21) and cytotoxicity to tumor cells (3,9,20). Another mechanism may be the control of the absolute number of MP cells in vivo. The number of MP cells at a local inflammation site increases not only by the migration of blood monocytes (26, 27) but also by the proliferation of the migrated cells at the inflammation site, probably depending on a growth factor produced by lymphocytes or by fibroblasts, as evidenced in vitro (5,8,11,24).